Statistics for ProQR Therapeutics NV (id:5489 PRQR)
Valuation metrics
Market cap
283.30M
Enterprise value
145.77M
Trailing P/E (ttm)
-7.51
Forward P/E
-5.69
PEG ratio
-5.69
Price/Sales (ttm)
15.41
Price/Book (mrq)
8.74
Enterprise Value/Revenue
7.59
Enterprise Value/EBITDA
-4.88
Overview
Shares outstanding
105.91M
Float
62.83M
Shares short
187.55K
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
797.76K
Average volume (90 days)
Price summary
52-Week low
1.61
52-Week high
4.62
52-Week change
23.57%
Beta
3.00
50-Day moving average
3.43
200-Day moving average
2.32
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-130.21%
Operating margin
-218.94%
Operational effectiveness
Return on assets
-14.86%
Return on equity
-67.14%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
1.81
Gross profit (ttm)
0.00
EBITDA
-29,878,494.00
Net income to common (ttm)
-25,006,853.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
180.51%
Balance sheet
Total cash (mrq)
93.38M
Total cash per share (mrq)
1.09
Total debt (mrq)
18.17M
Total Debt/Equity (mrq)
69.64
Current ratio (mrq)
233.10%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-33,807,978.00
Levered free cash flow (LFCF)
4.64M